Rahika Capmatinib 200mg Tablets 12's
Manufacturer: NOVARTIS INDIA LTD
Salt: CAPMATINIB 200MG
Category: Anti-Cancer
Price: $235
Availability: In Stock
Rahika 200mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.
Do not take this medicine if you are allergic to Rahika 200mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.
Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy. The common side effects of Rahika 200mg tablet are swelling in the face, and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite.
Non-small cell lung cancer (NSCLC)
Rahika Capmatinib 200mg Tablets 12's
Product Information
What is Rahika Capmatinib 200mg Tablets 12's?
Rahika 200mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.
Do not take this medicine if you are allergic to Rahika 200mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.
Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy. The common side effects of Rahika 200mg tablet are swelling in the face, and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite.
Indications for Rahika Capmatinib 200mg Tablets 12's
Non-small cell lung cancer (NSCLC)
Therapeutic Effects of Rahika Capmatinib 200mg Tablets 12's
Rahika 200mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET). It works by blocking the action of this abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
How to consume Rahika Capmatinib 200mg Tablets 12's
It is an orally available prescription drug. Your doctor will decide the dose and duration of Rahika 200mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.
Side Effects of Rahika Capmatinib 200mg Tablets 12's
Swelling in the face, and body
Decrease in appetite
Nausea
Cough
Fatigue
Vomiting
Liver injury
Muscle pain
Shortness of breath
Lung infection
Respiratory disease
Drug Interactions
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications interact with Rahika 200mg tablet and reduce its effectiveness by causing undesirable side effects.
Storage & Handling
Store at 20°C to 25°C
Protect the medicine from light and excessive moisture.
Keep the medicine out of reach of children and pets
If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
Expert Advice
Limit direct exposure to the sun or artificial ultraviolet (UV) light while using this medicine. Use sunscreen, wear sunglasses and protective clothing while you are going outdoors, and for at least 7 days after you stop taking it. Report immediately to your doctor if you have abdominal pain. This medicine may cause birth defects if either partner is using it during conception or pregnancy. If you are a female patient with reproductive potential, use an effective form of birth control during the treatment and for 1 week after the last dose. Male patients with female partners should use an effective form of birth control during treatment and for at least 1 week after the last dose. Do not breastfeed while using this medicine and for at least 1 week after your last dose. Your doctor may do lab tests to check the therapy's effectiveness or monitor the unwanted side effects.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Rahika Capmatinib 200mg Tablets 12's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Rahika Capmatinib 200mg Tablets 12's

Pregnancy
UnsafeDo not take Rahika 200mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 7 days after your last dose.

BreastFeeding
UnsafeBreastfeeding is not recommended in patients taking Rahika 200mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.

Liver
UnsafeRahika 200mg tablet should be used cautiously in patients with liver problems. Dose adjustments are necessary for liver failure patients. Inform your physician if you have any liver diseases before initiating the therapy.

Lungs
UnsafeRahika 200mg tablet should be cautiously administered in patients with lung problems other than lung cancer. Inform your physician if you have any lung diseases before initiating the therapy.

Alcohol
Consult your doctorIt is unknown whether it is safe to consume alcohol with Rahika 200mg tablet. Please consult your doctor.

Driving
Consult your doctorIt is unknown whether Rahika 200mg tablet alters the ability to drive or operate heavy machinery. If you feel dizzy or sleepy, avoid driving and consult your doctor.